1. Treatment of Clostridium difficile-Associated Disease
Daniel A. Leffler, J. Thomas Lamont 
Gastroenterology 
Volume 136, Issue 6, Pages (May 2009)
DOI: /j.gastro
Copyright © 2009 AGA Institute Terms and Conditions

2. Figure 1 Pathogenesis of C difficile infection.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2009 AGA Institute Terms and Conditions

3. Figure 2
Age-related prevalence of antibody to C difficile toxin A and B. Modified from Viscidi et al.6
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2009 AGA Institute Terms and Conditions

4. Figure 3
Recent increase in reported treatment failures for metronidazole. Modified from Aslam et al.46
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2009 AGA Institute Terms and Conditions

5. Figure 4
Equivalent response of low and high dose vancomycin. (Modified with permission from Fekety et al.42)
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2009 AGA Institute Terms and Conditions

6. Figure 5
Vancomycin is more effective than metronidazole for severe C difficile infection. Modified with permission from Zar et al.48
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2009 AGA Institute Terms and Conditions

7. Daniel A. Leffler
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2009 AGA Institute Terms and Conditions

8. J. Thomas Lamont
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2009 AGA Institute Terms and Conditions